Literature DB >> 11681847

Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency.

M Bohatschek1, A Werner, G Raivich.   

Abstract

The lipopolysaccharide (LPS) constituents of the gram-negative bacterial wall are among the most potent activators of inflammation. In the current study, we examined the effect of subcutaneous injection of Escherichia coli LPS on leukocyte influx into the normal and injured brain using endogenous peroxidase (EP). Normal brain parenchyma does not contain granulocytes and this does not change after indirect trauma, in facial axotomy. However, systemic injection of 1 mg LPS led to a gradual appearance of EP-positive parenchymal granulocytes within 12 h, with a maximum at 1-4 days after injection. Facial axotomy (day 14) led to a further 50-300% increase in granulocyte number. Of the five mouse strains tested in the current study, four--Balb/C, FVB, C57Bl/6, and C3H/N--showed vigorous granulocyte influx (60-90 cells per 20-microm section in axotomized facial nucleus, 20-40 cells per section on the contralateral side). The influx was an order of magnitude lower in the SJL mice. The peroxidase-positive cells were immunoreactive for neutrophil antigen 7/4 and alpha M beta 2 integrin, were negative for IBA1 (monocytes) and CD3 (T cells), and could be prelabeled by subcutaneous injection with rhodamine B isothiocyanate (RITC), confirming their origin as blood-borne granulocytes. All RITC-positive cells were IBA1 negative. This influx of granulocytes was accompanied by a disruption of the blood-brain barrier to albumin and induction of the cell adhesion molecule ICAM-1 on affected blood vessels. Transgenic deletion of ICAM-1 led to a more than 50% reduction in the number of infiltrating granulocytes compared to litter-matched wild-type controls, in normal brain as well as in axotomized facial motor nucleus. In summary, systemic injection of LPS leads to invasion of granulocytes into the mouse brain and a breakdown of the blood-brain barrier to blood-borne cells and to soluble molecules. Moreover, this mechanism may play a pathogenic role in the etiology of meningitis and in severe bacterial sepsis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681847     DOI: 10.1006/exnr.2001.7764

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  Evaluation of laser speckle contrast imaging as an intrinsic method to monitor blood brain barrier integrity.

Authors:  Suzie Dufour; Yaaseen Atchia; Raanan Gad; Dene Ringuette; Iliya Sigal; Ofer Levi
Journal:  Biomed Opt Express       Date:  2013-08-30       Impact factor: 3.732

Review 3.  Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis.

Authors:  Lucineia Gainski Danielski; Amanda Della Giustina; Marwa Badawy; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

4.  Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.

Authors:  Hey-Kyeong Jeong; Ilo Jou; Eun-hye Joe
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

Review 5.  Inflammation as a causative factor in the aetiology of Parkinson's disease.

Authors:  P S Whitton
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

6.  Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats.

Authors:  Chun-Hua Hang; Ji-Xin Shi; Jie-Shou Li; Wei Wu; Hong-Xia Yin
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Pathophysiology of age-related diseases.

Authors:  Giuseppina Campisi; Martina Chiappelli; Massimo De Martinis; Vito Franco; Lia Ginaldi; Rosario Guiglia; Federico Licastro; Domenico Lio
Journal:  Immun Ageing       Date:  2009-09-08       Impact factor: 6.400

Review 8.  Sensitization and tolerization to brain antigens in stroke.

Authors:  K J Becker
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

9.  Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults.

Authors:  Jennifer C Schiltz; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.

Authors:  Manuela Schaper; Stephen L Leib; Damian N Meli; Ralf P Brandes; Martin G Täuber; Stephan Christen
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.